Ewelina Biskup

1.9k total citations
60 papers, 929 citations indexed

About

Ewelina Biskup is a scholar working on Molecular Biology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ewelina Biskup has authored 60 papers receiving a total of 929 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Oncology and 12 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ewelina Biskup's work include Dermatologic Treatments and Research (5 papers), Ubiquitin and proteasome pathways (4 papers) and Breast Cancer Treatment Studies (4 papers). Ewelina Biskup is often cited by papers focused on Dermatologic Treatments and Research (5 papers), Ubiquitin and proteasome pathways (4 papers) and Breast Cancer Treatment Studies (4 papers). Ewelina Biskup collaborates with scholars based in China, Switzerland and Germany. Ewelina Biskup's co-authors include Fengfeng Cai, Minghong Wang, Xiaoyan Lin, Marcus Vetter, Hongwei Zhang, Chengjiao Zhang, Junjun Zhu, J Martínková, Maria Teresa Ferretti and Xin Pan and has published in prestigious journals such as PLoS ONE, Cancer Research and The Lancet Oncology.

In The Last Decade

Ewelina Biskup

53 papers receiving 918 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ewelina Biskup China 16 269 252 150 99 97 60 929
Hua Jin China 17 478 1.8× 223 0.9× 92 0.6× 85 0.9× 95 1.0× 60 1.8k
Navid Sadeghi United States 16 308 1.1× 315 1.3× 111 0.7× 127 1.3× 95 1.0× 61 860
Daniela Stan United States 22 214 0.8× 395 1.6× 91 0.6× 99 1.0× 56 0.6× 64 1.1k
Dan Su China 20 465 1.7× 163 0.6× 214 1.4× 96 1.0× 31 0.3× 72 1.1k
Emese Zsíros United States 17 262 1.0× 441 1.8× 97 0.6× 158 1.6× 110 1.1× 75 1.1k
Robert Watson United Kingdom 18 296 1.1× 346 1.4× 95 0.6× 136 1.4× 42 0.4× 41 1.2k
Hiroko Hashimoto Japan 20 341 1.3× 526 2.1× 240 1.6× 97 1.0× 44 0.5× 84 1.3k
Xiang Lu China 26 329 1.2× 214 0.8× 58 0.4× 179 1.8× 46 0.5× 79 1.8k
Fangkun Liu China 19 332 1.2× 270 1.1× 102 0.7× 156 1.6× 95 1.0× 31 1.4k
Hiromi Kimura Japan 19 552 2.1× 275 1.1× 68 0.5× 105 1.1× 72 0.7× 76 1.4k

Countries citing papers authored by Ewelina Biskup

Since Specialization
Citations

This map shows the geographic impact of Ewelina Biskup's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ewelina Biskup with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ewelina Biskup more than expected).

Fields of papers citing papers by Ewelina Biskup

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ewelina Biskup. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ewelina Biskup. The network helps show where Ewelina Biskup may publish in the future.

Co-authorship network of co-authors of Ewelina Biskup

This figure shows the co-authorship network connecting the top 25 collaborators of Ewelina Biskup. A scholar is included among the top collaborators of Ewelina Biskup based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ewelina Biskup. Ewelina Biskup is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Biskup, Ewelina, Céline Montavon, Andreas Müller, et al.. (2023). Pertuzumab as second‑ or later‑line therapy for human epidermal growth factor receptor 2‑positive metastatic breast cancer: A clinical experience. Molecular and Clinical Oncology. 19(1). 52–52. 1 indexed citations
2.
Wang, Yueming, Cong Meng, Wenjin Wang, et al.. (2023). Spatio-temporally deciphering peripheral nerve regeneration in vivo after extracellular vesicle therapy under NIR-II fluorescence imaging. Nanoscale. 15(17). 7991–8005. 12 indexed citations
3.
4.
Zhang, Hongyi, et al.. (2022). Long-term Survival After Diverse Therapeutic Modalities in Malignant Phyllodes Tumors of the Breast. Technology in Cancer Research & Treatment. 21. 2213862974–2213862974. 12 indexed citations
5.
Wang, Jiahong, Minghong Wang, Yi Zhang, et al.. (2022). IL‑6 inhibitors effectively reverse post‑infarction cardiac injury and ischemic myocardial remodeling via the TGF‑β1/Smad3 signaling pathway. Experimental and Therapeutic Medicine. 24(3). 576–576. 13 indexed citations
6.
Biskup, Ewelina, J Martínková, & Maria Teresa Ferretti. (2020). Gender medicine: Towards a gender-specific treatment of neuropsychiatric disorders. Handbook of clinical neurology. 175. 437–448. 9 indexed citations
7.
Demelo‐Rodríguez, Pablo, Francisco Galeano‐Valle, Andrea Salzano, et al.. (2020). Pulmonary Embolism. Heart Failure Clinics. 16(3). 317–330. 14 indexed citations
8.
9.
Cai, Fengfeng, et al.. (2019). Application of Circulation Tumor Cells Detection in Diagnosis and Treatment of Breast Tumors. Rejuvenation Research. 22(6). 498–502. 2 indexed citations
10.
Cai, Fengfeng, et al.. (2019). Anthracycline‑induced cardiotoxicity in the chemotherapy treatment of breast cancer: Preventive strategies and treatment (Review). Molecular and Clinical Oncology. 11(1). 15–23. 119 indexed citations
11.
Biskup, Ewelina, Céline Montavon, Andreas Müller, et al.. (2019). Pertuzumab (P) as ≥ second-line therapy for HER2-positive metastatic breast cancer (mBC): Swiss clinical experience. Annals of Oncology. 30. iii57–iii57.
12.
13.
Zhang, Chengjiao, et al.. (2018). Correction to: Depression Induced by Total Mastectomy, Breast Conserving Surgery and Breast Reconstruction: A Systematic Review and Meta‐analysis. World Journal of Surgery. 42(7). 2086–2086. 1 indexed citations
14.
Zhang, Chengjiao, et al.. (2018). Depression Induced by Total Mastectomy, Breast Conserving Surgery and Breast Reconstruction: A Systematic Review and Meta‐analysis. World Journal of Surgery. 42(7). 2076–2085. 41 indexed citations
15.
Biskup, Ewelina, Fengfeng Cai, & Marcus Vetter. (2017). Bone targeted therapies in advanced breast cancer. Swiss Medical Weekly. 147(2526). w14440–w14440. 18 indexed citations
16.
Biskup, Ewelina, et al.. (2015). Coma resulting from a grade IV anaphylactic reaction to atracurium. Revue française d'allergologie. 55(2). 64–67.
17.
Yang, Xiaoyu, Junjun Zhu, Ewelina Biskup, Fengfeng Cai, & Aijun Li. (2015). Inflammatory pseudotumors of the liver: experience of 114 cases. Tumor Biology. 36(7). 5143–5148. 15 indexed citations
18.
Cai, Fengfeng, Ping Chen, Li Chen, et al.. (2014). Human RAD6 Promotes G1-S Transition and Cell Proliferation through Upregulation of Cyclin D1 Expression. PLoS ONE. 9(11). e113727–e113727. 18 indexed citations
19.
Cai, Fengfeng, Isabell Ge, Minghong Wang, et al.. (2013). Pyrosequencing analysis of BRCA1 methylation level in breast cancer cells. Tumor Biology. 35(4). 3839–3844. 14 indexed citations
20.
Abedin, Zainab, Ewelina Biskup, Jane Garbutt, et al.. (2012). Deriving Competencies for Mentors of Clinical and Translational Scholars. Clinical and Translational Science. 5(3). 273–280. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hua Jin Breakdown of academic impact, for papers by Navid Sadeghi Breakdown of academic impact, for papers by Daniela Stan Breakdown of academic impact, for papers by Dan Su Breakdown of academic impact, for papers by Emese Zsíros Breakdown of academic impact, for papers by Robert Watson Breakdown of academic impact, for papers by Hiroko Hashimoto Breakdown of academic impact, for papers by Xiang Lu Breakdown of academic impact, for papers by Fangkun Liu Breakdown of academic impact, for papers by Hiromi Kimura
Rankless by CCL
2026